T Cell News and Research

Latest T Cell News and Research

SARS-CoV-2's resistance to remdesivir in vitro

A new preprint research paper posted to the bioRxiv server discusses the emergence of mutations in the SARS-CoV-2 virus, allowing it to escape the effects of the most commonly used antiviral drug, remdesivir.

14 Feb 2021

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Feb 2021

LMU researchers study T cell exhaustion

T lymphocytes, or T cells, are an important component of our immune system. They can recognize foreign proteins, so-called antigens, as peptide fragments - for instance, those derived from viruses or cancer cells.

13 Feb 2021

Researchers map the mechanism behind cellular communication

Knowledge on how cells communicate is an important key to understanding many biological systems and diseases.

13 Feb 2021

New zebrafish model could help advance glioblastoma multiforme research

Scientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research. Glioblastoma is an aggressive form of primary brain tumor - fewer than one in 20 patients survive five years after diagnosis.

13 Feb 2021

Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition

Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma.

13 Feb 2021

Revolutionary drug combination shows potential for treatment of fatal childhood cancer

Every year around 20 Australian children die from the incurable brain tumor, Diffuse Intrinsic Pontine Glioma (DIPG). The average age of diagnosis for DIPG is just seven years.

13 Feb 2021

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

13 Feb 2021

Major antioxidant in green tea may increase levels of natural anti-cancer protein

An antioxidant found in green tea may increase levels of p53, a natural anti-cancer protein, known as the "guardian of the genome" for its ability to repair DNA damage or destroy cancerous cells.

13 Feb 2021

Lund researchers discover how E. coli bacteria target and degrade MYC oncogene

Scientists at Lund University have discovered how E. coli bacteria target and degrade the well-known oncogene MYC, which is involved in many forms of cancer.

13 Feb 2021

Study describes mechanism that limits immunosupressive activity of tumor-associated macrophages

Tumor cells are able to avoid the attack of the immune system through several mechanisms. For instance, these can secrete factors that turn macrophages -cells in the immune system- into dual action agents that contribute to the tumor progress and will protect it from immune body defenses: these become, thus, the tumor-associated macrophages (TAMs).

13 Feb 2021

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer.

13 Feb 2021

T Cell News and Research

Latest T Cell News and Research

SARS-CoV-2's resistance to remdesivir in vitro

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

LMU researchers study T cell exhaustion

Researchers map the mechanism behind cellular communication

New zebrafish model could help advance glioblastoma multiforme research

Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition

Revolutionary drug combination shows potential for treatment of fatal childhood cancer

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Major antioxidant in green tea may increase levels of natural anti-cancer protein

Lund researchers discover how E. coli bacteria target and degrade MYC oncogene

Study describes mechanism that limits immunosupressive activity of tumor-associated macrophages

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

Novel finding could lead to better treatments for Type 1 and Type 2 diabetes

A novel approach to suppress the growth of glioblastoma cells

Webinar: High-Content Imaging on Human Pluripotent Stem Cell Research

New research aims to explore functions of bile acids in the gut stem cell niche

Disrupting cancer cell cycle with two commercially available inhibitors causes tumor cell death

A brain enzyme plays an important role in waking up neural stem cells

Researchers identify protein sequences involved in SARS-CoV-2 infection

Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic

Immunology eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in